No Data
No Data
Insider Sale: CHIEF EXECUTIVE OFFICER of $PTCT (PTCT) Sells 8,279 Shares
Insiders At PTC Therapeutics Sold US$1.2m In Stock, Alluding To Potential Weakness
PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
J.P. Morgan's Top Healthcare Stocks for 2025
Express News | PTC Therapeutics Inc: PTC's Fourth Approval Application Submitted to FDA in 2024
Express News | PTC Therapeutics Announces Vatiquinone Nda Submission to FDA for the Treatment of Children and Adults Living With Friedreich Ataxia